Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy.
暂无分享,去创建一个
P. Underhill | C. Guilleminault | E. Mignot | W. Dement | A. Kimura | C. Rattazzi | F. Grumet | A. Lattermann | G. Mueller‐Eckhardt | L. Lin | X. Lin | Akinori Kimura | S. Yasunaga | G. Mayer | S. Yasunaga | X. Lin | G. Mueller-eckhardt | Emmanuel Mignot | W. C. Dement | Christian Guilleminault | Ling Lin | Peter A. Underhill | Geert Mayer
[1] G. Mueller‐Eckhardt,et al. HLA and narcolepsy in a German population. , 2008, Tissue antigens.
[2] A. Rogers,et al. HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy , 1997, Neurology.
[3] S Beck,et al. Characterization of recombination in the HLA class II region. , 1997, American journal of human genetics.
[4] R. Wassmuth,et al. DQB1 promoter sequence variability and linkage in caucasoids. , 1996, Human immunology.
[5] G. Montoya,et al. Strategy for distinguishing a new DQB1 allele (DQB1*0611) from the closely related DQB1*0602 allele via sequence specific PCR or direct DNA sequencing. , 1996, Tissue antigens.
[6] M. Aldrich,et al. Major Histocompatibility Class II Molecules in the CNS: Increased Microglial Expression at the Onset of Narcolepsy in a Canine Model , 1996, The Journal of Neuroscience.
[7] J. McCluskey,et al. P541 - Diversity in DRB1-DQB1 haplotypes associated with DRB1*0301 , 1996 .
[8] S. Gessa,et al. HLA CW ARMS-PCR typing in the Sardianian population , 1996 .
[9] E. Thorsby,et al. DQCAR microsatellite polymorphisms in three selected HLA class II-associated diseases. , 1995, Tissue antigens.
[10] A. Arnaiz-Villena,et al. HLA allele and haplotype frequencies in Algerians: Relatedness to Spaniards and Basques , 1995 .
[11] E. Mignot,et al. Extensive polymorphism of a (CA)n microsatellite located in the HLA-DQA1/DQB1 class II region. , 1995, Human immunology.
[12] P. Underhill,et al. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. , 1994, Sleep.
[13] E. Mignot,et al. Neuropharmacology and neurochemistry of canine narcolepsy. , 1994, Sleep.
[14] P. Stastny,et al. HLA class II DNA typing in two Brazilian populations. , 1993, Tissue antigens.
[15] E. Albert,et al. A deletion in the second exon of an HLA-DRB1 allele found in a DR2-negative narcolepsy patient. , 1993, Human immunology.
[16] A. Arnaiz-Villena,et al. Evolutionary relationships of HLA-DR8 alleles and description of a new subtype (DRB1*0806) in the Algerian population. , 1993, Human immunology.
[17] M. Billiard,et al. Autoimmune hypothesis in narcolepsy , 1993, Neurophysiologie Clinique/Clinical Neurophysiology.
[18] G. Hitman,et al. Distribution of HLA-DQA1, -DQB1 and DRB1 alleles in black IDDM patients and controls from Zimbabwe. , 1992, Tissue antigens.
[19] T. Sasazuki,et al. DNA typing of HLA class II genes in B-lymphoblastoid cell lines homozygous for HLA. , 1992, Tissue antigens.
[20] C. Hurley,et al. New DQwl diversity identified within DRwl2 and DRwl4 haplotypes , 1991 .
[21] P. Stastny,et al. HLA class II haplotypes in Amerindians and in black North and South Americans. , 1991, Tissue antigens.
[22] B. Arendse,et al. HLA class II specificities and haplotypes in South Africa detected using polymerase chain reaction and sequence-specific oligonucleotide typing. , 1991, Tissue antigens.
[23] M. Lovett,et al. Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[24] E. Thorsby,et al. Novel HLA-DR2 and -DR3 haplotypes among Norwegian Caucasians. , 1991, Tissue antigens.
[25] M. Billiard,et al. CSF immune variables in patients with narcolepsy , 1990, Acta neurologica Scandinavica.
[26] M. Aldrich,et al. Narcolepsy associated with lesions of the diencephalon , 1989, Neurology.
[27] M. Mitler,et al. HLA-DR2 association with excessive somnolence in narcolepsy does not generalize to sleep apnea and is not accompanied by systemic autoimmune abnormalities. , 1988, Clinical immunology and immunopathology.
[28] J. Strominger,et al. Molecular organization of the DQ subregion (DO-DX-DV-DQ) of the human MHC and its evolutionary implications. , 1988, Journal of immunology.
[29] J. Spire,et al. HLA antigens in narcolepsy , 1987, Neurology.
[30] D. Vergani,et al. Immune factors in narcolepsy. , 1986, Sleep.
[31] A. Besset,et al. HLA-DR2 and narcolepsy. , 1986, Sleep.
[32] M. Satake,et al. Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics. , 1985, The Journal of clinical investigation.
[33] M. Satake,et al. HLA antigens in Japanese patients with narcolepsy , 1984 .
[34] T. Sasazuki,et al. Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM). , 1996, Tissue antigens.
[35] E. Mignot,et al. Narcolepsy and immunity. , 1995, Advances in neuroimmunology.
[36] A. Kimura,et al. Polymorphism in the upstream regulatory region of DQA1 genes and DRB1, QAP, DQA1, and DQB1 haplotypes in the German population. , 1994, Human Immunology.
[37] H. Inoko. DNA Typing in Narcolepsy , 1988 .
[38] T. Juji,et al. Immunological Features of Narcolepsy in Japan , 1988 .
[39] R. Vaughan,et al. HLA in Narcolepsy/Cataplexy in the United Kingdom , 1988 .
[40] C. Guilleminault,et al. HLA-DR2 and the Narcolepsy Syndrome: The Stanford Experience , 1988 .
[41] J. Montplaisir,et al. HLA antigens in narcolepsy and idiopathic central nervous system hypersomnolence. , 1986, Sleep.